Wockhardt Limited
Records under this name other than the patents Wockhardt Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,857,138 | Pharmaceutical compositions comprising antibacterial agents Lapsed on the fee record Ended Dec 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 8, 2024 | From the USPTO record |
| US 10,857,171 | Pharmaceutical compositions Lapsed on the fee record Ended Dec 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 8, 2024 | From the USPTO record |
| US 8,097,594 | Macrolides and ketolides having antimicrobial activity Lapsed on the fee record Ended Jan 17, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 17, 2024 | From the USPTO record |
| US 7,164,023 | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate Term ended Ended no later than Dec 31, 2023 · From the USPTO record | Term ended | Ended no later than Dec 31, 2023 | From the USPTO record |
| US 10,519,155 | 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their bacterial infections Lapsed on the fee record Ended Dec 31, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 31, 2023 | From the USPTO record |
| US 10,500,195 | Antibacterial compounds Lapsed on the fee record Ended Dec 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2023 | From the USPTO record |
| US 10,501,464 | 7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide containing compounds and their use in treating bacterial infections Lapsed on the fee record Ended Dec 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2023 | From the USPTO record |
| US 10,485,812 | Stable antibacterial composition Lapsed on the fee record Ended Nov 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 26, 2023 | From the USPTO record |
| US 9,127,004 | Nitrogen containing heterocyclic compounds Lapsed on the fee record Ended Sep 8, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2023 | From the USPTO record |
| US 10,376,649 | Drug delivery device for delivery of two or more independently user selectable multiple doses of medicaments with user operable variable dose locking mechanisms Lapsed on the fee record Ended Aug 13, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2023 | From the USPTO record |